KF
LinkedIn

Karen Facey

Scientific Advisor in HTA

Drymen, Scotland, United Kingdom · 1 connection

University of Oxford

Not on Unlinked · Imported profile. Is this you? Claim it

About

Following a career as a statistician in the pharmaceutical industry and medicines regulation, Karen entered the field of Health Technology Assessment (HTA). HTA is a multidisciplinary policy analysis of the medical, social, ethical and economic impacts of the introduction, diffusion and disinvestment of health interventions. Karen is passionate about holistic assessment of the impact of interventions in health systems using robust evidence in a variety of forms to inform accountable decision making. This is not just an academic interest, as a Non Executive Director in a Scottish health board for 8 years Karen was also fully aware of the real-life challenges in setting health care priorities when budgets are limited and efficency pressures increase. She also chaired the government committee that created the new funding formula for the NHS (NRAC). She has a critical eye for value assessment and is an engaging presenter and experienced facilitator. In 2014, Karen was named as one of the top 100 practising scientists in the UK. Specialties: Statistics, Health Technology Assessment (HTA) Health provision Health policy Patient involvement in HTA

Experience

Senior Advisor, HTAFIPRA Public Affairs
Apr 2023
Visiting Senior Research FellowUsher Institute, The University of Edinburgh
Apr 2021
Member of Scottish Health Technologies CouncilHealthcare Improvement Scotland
Apr 2011
Evidence Based Health Policy ConsultantSelf-employed Basic company page — company details not listed yet
Oct 2003
Member of Patient and Public Involvement Standing GroupHealth Technology Wales
Apr 2019 to Apr 2025
Honorary Senior Research FellowGlasgow Univeristy Basic company page — company details not listed yet
May 2009 to May 2014
Non Executive DirectorNHS Health Scotland
Apr 2011 to Mar 2014
Non Executive DirectorNHS Forth Valley
Jan 2004 to Jan 2012
Statistical ConsultantPfizer
Jan 1999 to Jan 2000
Senior Statistical AssessorMedicines and Healthcare products Regulatory Agency
Jun 1995 to Oct 1999

Education

University of Reading
PhD, Interim Analysis in Clinical Trials
1987 to 1991
City St George’s, University of London
BSc (Hons) with industrial applications, Statistics
1982 to 1986